Subsequent malignancies in patients irradiated for testicular tumours

The British Journal of Radiology
J H HayG R Kerr

Abstract

897 patients received radiotherapy in Scotland for tumours of the testis between 1950-1969. 299 patients who died within two years of treatment, and a further 51 patients with inadequate follow-up data, were excluded from a survey of the incidence of second tumours. 547 patients with a mean follow-up of 15.4 years were included in the study. Fifty-one second and six third malignancies were found. The observed incidence is significantly higher than expected (ratio 1.87; p less than 0.001), both in the irradiated sites (ratio 1.94; p less than 0.05) and in unirradiated sites (ratio 1.99; p less than 0.01). These patients have a higher incidence of second testicular tumours (ratio 23.1; p less than 0.001). Analysis of the incidence of new malignancies in successive quinquennia after irradiation shows a significantly higher incidence in two periods. Within five years the greater incidence (p less than 0.05) is due mainly to the occurrence of second testicular tumours. In the period 15-19 years after irradiation the higher incidence (p less than 0.01) is accounted for by tumours arising in the urinary and gastro-intestinal tracts. The increased risk of developing a second cancer is low and there was no observed increase in radiation...Continue Reading

References

Jul 28, 1977·The New England Journal of Medicine·R R ReimerR C Young
Sep 1, 1977·British Journal of Cancer·P Prior, J A Waterhouse
Mar 1, 1975·British Journal of Cancer·J F Bithell, A M Stewart
Jan 1, 1973·British Medical Bulletin·R H Mole
Apr 1, 1971·Clinical Radiology·J KirkE R Watson
Jan 26, 1980·British Medical Journal·P ValagussaG Bonadonna
Dec 1, 1981·The Journal of Urology·D F Lynch, H W Herr
Mar 1, 1964·British Journal of Urology·S WESOLOWSKI, T KRZESKI

❮ Previous
Next ❯

Citations

Nov 20, 1998·Lancet·A HorwichD Dearnaley
Oct 27, 1998·International Journal of Radiation Oncology, Biology, Physics·G S BaumanE W Winquist
Apr 1, 1995·The British Journal of Radiology·K A VallisG R Kerr
Dec 1, 1986·The British Journal of Radiology·M D LeslieM J Peckham
Feb 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E H WanderåsS Tretli
Feb 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E H WanderåsS Tretli
Apr 1, 1993·British Journal of Urology·J R Germa LluchF J Sole Balcells
Aug 1, 1991·British Journal of Urology·E P AllhoffB Schneider
May 1, 1996·International Journal of Radiation Oncology, Biology, Physics·G M Thomas
Apr 1, 1997·International Journal of Radiation Oncology, Biology, Physics·K D JacobsenS D Fosså
Jun 22, 2012·Journal of Gastrointestinal Cancer·Joan CostelloeJohn V Reynolds
Jan 1, 1994·International Urology and Nephrology·M SteinA Kuten
Aug 19, 2007·Cancer Causes & Control : CCC·Sharon R SilverRobert D Daniels
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·N AassH Høst
Jan 23, 2010·Cancer Treatment Reviews·Kyriaki Pliarchopoulou, Dimitrios Pectasides
Feb 1, 1989·International Journal of Radiation Oncology, Biology, Physics·S D FossåO Kaalhus
Jan 15, 1994·International Journal of Radiation Oncology, Biology, Physics·P P LaiN A Kucik
Apr 30, 1994·International Journal of Radiation Oncology, Biology, Physics·R T OliverW R Pratt
Jun 1, 1990·International Journal of Radiation Oncology, Biology, Physics·A HellbardtJ P Paunier
Sep 25, 2009·Clinical Oncology : a Journal of the Royal College of Radiologists·P ChungUNKNOWN Genitourinary Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care
Jun 1, 1986·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C HamiltonM J Peckham
Feb 1, 1991·Urology·F H DexeusD Grignon
May 1, 1989·Urology·W M O'BrienW C Maxted
Apr 1, 1987·British Journal of Urology·M J PeckhamW F Hendry
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G K JacobsenH Møller
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H MøllerH H Storm
Sep 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C GlanzmannU M Lütolf
Mar 1, 1994·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A Horwich, J Bell
May 1, 1992·Clinical Oncology : a Journal of the Royal College of Radiologists·A M Brunt, J E Scoble
Nov 1, 1987·Clinical Radiology·P M Quilty, G R Kerr
Sep 1, 1990·Clinical Oncology : a Journal of the Royal College of Radiologists·A D Steinfeld, R E Shore
Sep 5, 1998·The Urologic Clinics of North America·G D Grossfeld, E J Small
Jun 16, 2015·Urologic Oncology·Stephanie A CurreriClair J Beard
Nov 5, 1997·Journal of the National Cancer Institute·C R Nichols, P J Loehrer
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexandra W van den Belt-DuseboutFlora E van Leeuwen
Jun 1, 1990·Clinical Radiology·J F OlliffM P Williams
Jan 1, 1994·Clinics in Dermatology·R TokarekJ B Mitchell
Sep 1, 1989·International Journal of Radiation Oncology, Biology, Physics·R L CumberlinK L Mossman
Dec 10, 1999·Seminars in Surgical Oncology·C KollmannsbergerC Bokemeyer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
A Horwich, J Bell
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
C R HamiltonM J Peckham
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
H MøllerHans Storm
© 2021 Meta ULC. All rights reserved